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Background
An estimated 200 million people worldwide have type 2
diabetes. Type 2 diabetes is recognized as an independent
risk factor for adverse cardiac events, such as myocardial
infarction. Cardiovascular disease is the leading cause of
death amongst diabetic patients. The subclinical pathophy-
siology of diabetic heart disease predicts global microvas-
cular disease, prior to the onset of overt ischemic heart
disease. Non-invasive screening methods are therefore
important for risk stratification of asymptomatic patients.
Cardiovascular Magnetic Resonance Imaging (CMR) is a
valuable tool for the assessment of subclinical microvascu-
lar function in this high-risk population.
Objectives
To assess the degree of cardiac microvascular dysfunc-
tion in individuals type 2 diabetes (T2D) without coron-
ary disease or hypertension, compared to healthy, non-
diabetic controls.
Methods
This cross sectional pilot data included 2 groups of sub-
jects: Patients diagnosed with type 2 diabetes (HbA1c
7.5-9.9%; mean age 59.3±7.17; n=6), and healthy,
non-diabetic age-matched controls (mean age 51.9±10.3;
n=10). Medical history and ECG were reviewed to rule
out ischemic heart disease. Qualified patients underwent
a CMR-Adenosine stress perfusion,
Results
Subendocardial perfusion delays were observed in 4 out of
6 diabetic patients, and 0 of 10 healthy controls (p < 0.05).
Importantly, the T2D patients exhibited primarily diffuse
or circumferential perfusion deficits (Figure 1). Controls
were normotensive (125.3/79.7 mmHg ± 6.1/2.8 mmHg),
and patients had controlled blood pressure (mean 132.2/
79.8 mmHg ± 8.5/5.2 mmHg), primarily through ACE
inhibitors. Patients and controls had normal systolic func-
tion (LV EF 57.7 ± 3.01 and 57.8 ± 5.4, respectively).
Conclusion
The observed perfusion abnormality supports previous
nuclear imaging findings and pathophysiological
research of diabetic heart disease and may indicate more
diffuse patterns of microvascular disease. Further studies
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Figure 1 Stress perfusion image from patient diagnosed with a
type 2 diabetes in 2009. Note circumferential subendocardial
perfusion delay.
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